Ekso Bionics Holdings Inc (EKSO)
1.365
-0.06
(-3.87%)
USD |
NASDAQ |
Mar 28, 16:00
1.37
0.00 (0.00%)
After-Hours: 20:00
Ekso Bionics Holdings Research and Development Expense (Quarterly): 1.313M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.313M |
September 30, 2023 | 1.159M |
June 30, 2023 | 1.398M |
March 31, 2023 | 1.154M |
December 31, 2022 | 0.946M |
September 30, 2022 | 0.887M |
June 30, 2022 | 0.873M |
March 31, 2022 | 0.921M |
December 31, 2021 | 0.619M |
September 30, 2021 | 0.618M |
June 30, 2021 | 0.709M |
March 31, 2021 | 0.603M |
December 31, 2020 | 0.712M |
September 30, 2020 | 0.599M |
June 30, 2020 | 0.452M |
March 31, 2020 | 0.711M |
December 31, 2019 | 0.564M |
September 30, 2019 | 1.149M |
June 30, 2019 | 1.499M |
March 31, 2019 | 1.384M |
Date | Value |
---|---|
December 31, 2018 | 1.368M |
September 30, 2018 | 1.282M |
June 30, 2018 | 1.389M |
March 31, 2018 | 1.808M |
December 31, 2017 | 1.992M |
September 30, 2017 | 1.986M |
June 30, 2017 | 2.632M |
March 31, 2017 | 2.873M |
December 31, 2016 | 2.293M |
September 30, 2016 | 2.216M |
June 30, 2016 | 2.221M |
March 31, 2016 | 2.149M |
December 31, 2015 | 2.042M |
September 30, 2015 | 1.713M |
June 30, 2015 | 1.742M |
March 31, 2015 | 0.983M |
December 31, 2014 | 1.304M |
September 30, 2014 | 1.096M |
June 30, 2014 | 0.6989M |
March 31, 2014 | 0.7685M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.452M
Minimum
Jun 2020
1.499M
Maximum
Jun 2019
0.9135M
Average
0.88M
Median
Research and Development Expense (Quarterly) Benchmarks
Vicarious Surgical Inc | 8.468M |
Perspective Therapeutics Inc | 5.721M |
Xtant Medical Holdings Inc | 0.49M |
Asensus Surgical Inc | 8.614M |
Catheter Precision Inc | 0.112M |